Cephalon Inks Deal To Market Fentora In China
This article was originally published in PharmAsia News
Executive Summary
Cephalon has entered into a master services agreement with Beijing Med-Pharm to undertake the registration process for certain Cephalon products in the People's Republic of China, Med-Pharm announced Dec. 11